Thyroid Dysfunction: Reproduction and Postpartum Thyroiditis

John H. Lazarus

doi:10.1055/s-2002-36711

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2002; 20(4): 381-388
DOI: 10.1055/s-2002-36711

Thyroid Dysfunction: Reproduction and Postpartum Thyroiditis

John H. Lazarus

Department of Medicine, University of Wales College of Medicine, Cardiff, United Kingdom

Abstract

ABSTRACT

Thyroid function during pregnancy is characterized by changes in circulating thyroid hormone concentrations related to alterations in thyroxine binding globulin (TBG), human chorionic gonadotropin (hCG), and iodine status. The immunology of normal pregnancy shows a reduction in antibody titer during gestation and an increase in T helper-2 (TH2) immune responses. Thyroid dysfunction may cause menstrual disturbances in hyper- and hypothyroidism but less marked disturbances of sexual function in men. Fertility is reduced in hypo- and hyperthyroid females. Accumulating evidence suggests a strong association between the presence of thyroid antibodies and fetal loss, although the data relating to recurrent abortion are not so convincing. Asymptomatic maternal gestational hypothyroidism may occur in up to 2.5% of women; studies have shown a significant impact of this condition in causing a decrease of child IQ, suggesting that screening for maternal hypothyroidism with intervention may be justified. Postpartum thyroid disease occurs in 5 to 9% of women and thyroid dysfunction postpartum is seen in 50% of thyroid peroxidase antibody positive (TPO Ab+ve) women. There is a significant rate of hypothyroidism in long-term follow-up of women who have transient postpartum thyroid dysfunction.

KEYWORD

Pregnancy - antibodies - postpartum - immunology - thyroid

Volltext

Referenzen

REFERENCES

1 Chin W W, Yen P M. Molecular mechanisms of nuclear thyroid hormone action. In: Braverman LE, ed. Diseases of the Thyroid Totowa, NJ: Humana Press 1997: 1-15
2 Weetman A P, McGregor A M. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev . 1994; 15 788-830
3 Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev . 1997; 18 871-887
4 World Health Organization (WHO), United Nations Children's Fund (UNICEF), International Council for Control of Iodine Deficiency Disorders (ICCIDD) 1999. Progress towards the elimination of iodine deficiency disorders (IDD). WHO booklet, pp. 1-33
5 Brent G A. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol . 1997; 40 3-15
6 Weetman A P. The immmunology of pregnancy. Thyroid . 1999; 9 643-646
7 Ludgate M, Jasani B. Apoptosis in autoimmune and non-autoimmune thyroid disease. J Pathol . 1997; 182 123-124
8 Russell A S. Biology of human pregnancy: immune modulation (TH1 and TH2 responses in pregnancy). Scand J Rheumatol . 1998; 27 14-17
9 Pepe G J, Albrecht E D. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev . 1995; 16 608-648
10 Davies T F. The thyroid immunology of the postpatum period. Thyroid . 1999; 9 675-684
11 Elenkov I J, Wilder R L, Bakalov V K. IL-12, TNF-α, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab . 2001; 86 4933-4938
12 Longcope C. The male and female reproductive systems in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text Philadelphia: Lippincott Williams & Wilkins 2000: 652-658
13 Krassas G E, Pontikides N, Kaltsas T. Disturbances of menstruation in hypothyroidism. Clin Endocrinol . 1999; 50 655-659
14 Jannini E A, Ulisse S, D'Armiento M. Thyroid hormone and male gonadal function. Endocr Rev . 1995; 16 443-459
15 Abramson J, Stagnaro-Green A. Thyroid antibodies and fetal loss: an evolving story. Thyroid . 2001; 11 57-63
16 Stagnaro-Green A S, Roman S H, Cobin R H, El-Harazy E, Alvarez-Marfany M, Davies T. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA . 1990; 264 1422-1425
17 Glinoer D, Fernandez-Soto M, Bourdoux P. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab . 1991; 73 421-427
18 Lejeune B, Grun J P, deNayer P, Servais G, Glinoer D. Antithyroid antibodies underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension. Br J Obstet Gynecol . 1993; 100 669-672
19 Singh A, Dantas Z N, Stone S, Asch R. Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril . 1995; 63 277-281
20 Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y. Effects of autoantibodies of the course of pregnancy and fetal growth. Obstet Gynecol . 1997; 90 364-369
21 Imaizumi M, Prisker A, Unger P, Davies T F. Intrathyroidal fetal microchimerism in pregnancy and post partum. Endocrinology . 2002; 143 247-253
22 Srivatsa B, Srivatsa S, Johnson K L, Samura O, Lee S L, Bianchi D W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet . 2001; 358 2034-2038
23 Nelson J L. Michrochimerism: expanding new horizon in human health or incidental remnant of pregnancy?. Lancet . 2001; 358 2011-2012
24 Morreale de Escobar G, Obregón M J, Escobar del R ey. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?. J Clin Endocrinol Metab . 2000; 85 3975-3987
25 Haddow J E, Palomaki G E, Allan W C. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med . 1999; 341 549-555
26 Pop V J, Kuijpens J L, van Baar L A. Low maternal free thyroxine concentrations during early pergnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol . 1999; 50 149-155
27 Pop V J, de Vries E, van Baar L A. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development?. J Clin Endocrinol Metab . 1995; 80 3561-3566
28 Mandel S J, Reed Larsen P, Seeley E W, Brent G A. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med . 1990; 323 91-96
29 Gonzalez-Jimenez A, Fernandez-Soto M L, Escobar-Jimenez F, Glinoer D, Navarrete L. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy. Thyroidology . 1993; 5 13-20
30 Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organised by the European Thyroid Association. Eur J Endocrinol . 1998; 139 584-590
31 Lazarus J H, Hall R, Othman S. The clinical spectrum of postpartum thyroid disease. Q J Med . 1996; 89 429-435
32 Lazarus J H, Kokandi A. Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol . 2000; 53 265-278
33 Muller A F, Drexhage H A, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev . 2001; 22 605-630
34 Harris B, Othman S, Davies J. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ . 1991; 305 152-156
35 Adams H, Jones M C, Othman S. The sonographic appearances in postpartum thyroiditis. Clin Radiol . 1992; 45 311-318
36 Creagh F M, Parkes A B, Lee A. The iodide perchlorate discharge test in women with previous post-partum thyroiditis: relationship to sonographic appearance and thyroid function. Clin Endocrinol . 1994; 40 765-768
37 Stagnaro-Green A, Roman H, Cobin R H, El-Harazy E, Wallenstain S, Davies T F. Prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab . 1992; 74 645-653
38 Imaizumi M, Pritsker A, Kita M, Ahmad L, Unger P, Davies T. Pregnancy and murine thyroiditis: thyroglobulism immunization leads to fetal loss in specific allogenetic pregnancies. Endocrinology . 2001; 142 823-829
39 Premawardhana L D, Parkes A B, Ammari F. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab . 2000; 85 71-75
40 Lazarus J H, Ludgate M E. Prevention and treatment of postpartum Graves' disease. In: Davies TF, ed. Baillière's Clinical Endocrinology and Metabolism London: WB Saunders 1997: 549-560